JELLISEE OPHTHALMICS INC.

Profile

Company Names

JELLISEE OPHTHALMICS INC.

Addresses

8414 HOLLY LEAF DR., MCLEAN, VA 22102

Phone Numbers

216-970-8243

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$3,725,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2023-12-21 
$3,725,000.00 
$10,000,000.00 
$6,275,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JERRY 
 
ARTHUR 
DIRECTOR
GRAM ACQUISITION, LLC   |  GRAM NEWCO, INC.   |  GRAND RIVER ASEPTIC MANUFACTURING, INC.   |  GRAM ACQUISITION 2.0, LLC   |  JELLISEE OPHTHALMICS INC.
DIMITRI 
 
AZAR 
DIRECTOR
JELLISEE OPHTHALMICS INC.
FORREST 
J 
ELLIS 
EXECUTIVE OFFICER, DIRECTOR
JELLISEE OPHTHALMICS INC.
ADRIENNE 
 
GRAVES 
DIRECTOR
OCCULOGIX, INC.   |  AERPIO THERAPEUTICS, INC.   |  ENCORE VISION, INC.   |  TEARLAB CORP   |  ENVISIA THERAPEUTICS, INC.   |  SURFACE PHARMACEUTICALS, INC.   |  GREENBROOK TMS INC.   |  THEROPTIX, INC.   |  SURFACE OPHTHALMICS, INC.   |  OPUS GENETICS INC.   |  JELLISEE OPHTHALMICS INC.   |  QLARIS BIO, INC.
AMY 
R. 
JEFFERY 
EXECUTIVE OFFICER, DIRECTOR
JELLISEE OPHTHALMICS INC.
MICHAEL 
J. 
MALESARDI 
EXECUTIVE OFFICER, DIRECTOR
JELLISEE OPHTHALMICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-04-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-12-21 
2024-01-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-12-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#